Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln
29/08/2024 05:02
Aug 29 (Reuters) - China Shineway Pharmaceutical Group H1 gross margin 75.3%. * H1 net income RMB 626.5 million
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln